Q4 2025 Stryker Corp Earnings Call Transcript
Key Points
- Stryker Corp (SYK) reported outstanding financial results for 2025, with organic sales growth of 11% for Q4 and 10.3% for the full year, surpassing $25 billion in sales.
- The company achieved double-digit organic sales growth in key segments such as neurocranial endoscopy instruments and trauma extremities, indicating robust demand across its product portfolio.
- Stryker Corp (SYK) delivered a second consecutive year of at least 100 basis points of adjusted operating margin expansion, showcasing strong operational execution.
- The Mako robotic systems saw record installations, with over 3,000 systems worldwide, and increased utilization rates, reinforcing Stryker's leading position in US knees and hips.
- The company has a strong financial position, providing the capability to execute on mergers and acquisitions in 2026, supporting future growth opportunities.
- Stryker Corp (SYK) faced tariff headwinds, which impacted operating margins despite overall strong financial performance.
- The vascular segment experienced competitive pressures in the ischemic business, affecting overall growth in that division.
- Supply constraints in 2025 posed challenges, although they are not expected to impact growth rates in 2026.
- The European capital environment was slower, impacting sales growth in that region compared to other international markets.
- Foreign currency translation had an unfavorable impact on earnings per share, affecting financial results.
Welcome to the fourth quarter and full year 2025 Stryker earnings call. My name is Leila, and I'll be your operator for today's call. (Operator Instructions) This conference call is being recorded for replay purposes.
Before we begin, I would like to remind you that the discussions during this conference call will include forward-looking statements. Factors that could cause actual results to differ materially are discussed in the company's most recent filings with the SEC.
Also, the discussions will include certain non-GAAP financial measures. Reconciliations to the most directly comparable GAAP financial measures can be found in today's press release that is an exhibit to Stryker's current report on Form 8-K filed today with the SEC.
I will now turn the call over to Mr. Kevin Lobo, Chair and Chief Executive Officer. You may proceed, sir.
Welcome to Stryker's fourth-quarter earnings call. Joining me today are Preston Wells, Stryker's CFO; and Jason
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
